Insider Trading activities of Cytokinetics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytokinetics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cytokinetics Inc since year 2005. Table 2 shows the detailed insider transactions of Cytokinetics Inc since 2005. The reporting company's ticker symbol is CYTK. The reporting company's CIK number is 1061983.
The total value of stock buying since 2005 is $7,777,414.
The total value of stock sales since 2005 is $14,534,105.
The total value of stock option exercises since 2005 is $2,442,213.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Cytokinetics Inc (CYTK).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 23,181 $350,267 16,583 $96,199
2017-09 0 $0 30,362 $443,837 15,231 $87,316
2017-08 0 $0 149,678 $2,200,818 142,868 $1,150,599
2017-07 0 $0 5,000 $60,780 0 $0
2017-06 0 $0 5,000 $68,125 0 $0
2016-12 0 $0 5,633 $69,632 0 $0
2015-08 11,000 $72,050 0 $0 0 $0
2015-05 10,000 $57,070 0 $0 0 $0
2015-03 0 $0 21,875 $170,843 21,875 $137,812
2014-12 0 $0 21,630 $145,915 0 $0
2014-05 10,850 $44,430 0 $0 0 $0
2014-02 500,000 $4,000,000 0 $0 0 $0
2013-09 0 $0 0 $0 85,414 $0
2012-11 0 $0 1,742,950 $1,063,199 0 $0
2012-09 0 $0 0 $0 512,500 $0
2010-06 0 $0 91,146 $266,613 75,000 $43,497
2010-05 0 $0 1,078,219 $3,252,119 35,000 $26,499
2010-04 0 $0 10,000 $31,750 10,000 $12,000
2010-03 0 $0 10,000 $32,340 10,000 $12,000
2010-02 0 $0 1,000 $3,050 1,000 $1,200
2010-01 0 $0 1,000 $3,225 1,000 $1,200
2009-12 0 $0 123,906 $380,853 119,406 $99,620
2009-11 0 $0 182,000 $619,219 153,740 $166,545
2009-10 0 $0 8,500 $43,870 1,000 $1,200
2009-09 0 $0 11,000 $53,462 1,000 $1,200
2009-08 0 $0 64,000 $180,451 64,000 $38,049
2009-07 0 $0 2,000 $5,550 2,000 $2,400
2009-06 0 $0 102,000 $292,169 2,000 $2,400
2009-05 1,522,840 $2,999,994 7,676 $15,375 7,676 $9,211
2009-04 0 $0 28,324 $56,648 28,324 $33,988
2009-03 0 $0 32,500 $62,800 27,500 $29,589
2009-02 0 $0 5,000 $10,700 0 $0
2009-01 0 $0 5,000 $14,040 0 $0
2008-12 0 $0 5,000 $11,065 0 $0
2008-11 0 $0 5,000 $14,660 0 $0
2008-09 0 $0 45,838 $221,770 5,838 $7,005
2008-08 0 $0 14,976 $77,753 13,565 $16,277
2008-07 0 $0 20,651 $103,255 13,302 $26,604
2008-04 0 $0 2,000 $6,630 0 $0
2008-03 0 $0 2,000 $6,770 0 $0
2008-02 0 $0 2,000 $7,000 0 $0
2008-01 0 $0 3,000 $13,559 0 $0
2007-12 0 $0 16,702 $88,031 13,702 $21,804
2007-11 0 $0 23,814 $120,932 20,814 $36,028
2007-10 0 $0 31,656 $171,145 22,656 $39,712
2007-09 0 $0 22,874 $114,338 41,874 $58,148
2007-08 20,000 $101,420 23,045 $116,894 50,045 $56,614
2007-07 0 $0 22,582 $122,905 7,327 $8,588
2007-06 0 $0 30,725 $192,431 34,500 $39,230
2007-05 0 $0 7,800 $51,999 0 $0
2007-04 0 $0 1,500 $10,578 0 $0
2007-03 0 $0 1,500 $10,680 0 $0
2007-02 0 $0 8,500 $67,216 7,000 $8,400
2007-01 0 $0 15,200 $129,008 12,000 $14,400
2006-12 0 $0 15,200 $108,412 12,000 $9,130
2006-11 0 $0 25,200 $188,957 22,000 $15,859
2006-10 0 $0 30,200 $201,563 27,000 $18,759
2006-09 0 $0 20,200 $137,727 17,000 $12,959
2006-08 0 $0 24,199 $143,800 21,999 $15,858
2006-07 0 $0 24,197 $144,393 21,997 $15,856
2006-06 0 $0 15,195 $102,470 11,995 $6,956
2006-05 0 $0 30,063 $214,423 26,863 $18,678
2006-04 0 $0 26,867 $200,804 23,667 $15,825
2006-03 0 $0 24,263 $171,453 21,063 $14,315
2006-02 40,000 $290,175 20,450 $148,737 18,250 $12,684
2005-11 0 $0 158,900 $1,215,097 0 $0
2004-04 25,000 $212,275 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Cytokinetics Inc insiders (CYTK)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-06 Mcdowell Caryn Gordon (GC & Chief Compliance Officer) Sale 13,181 15.53 204,727
2017-10-06 Mcdowell Caryn Gordon (GC & Chief Compliance Officer) Option Ex 11,583 6.57 76,100
2017-10-02 Blum Robert I (President & CEO) Sale 5,000 14.55 72,770
2017-10-02 Gage L Patrick (Director) Sale 5,000 14.55 72,770
2017-10-02 Gage L Patrick (Director) Option Ex 5,000 4.02 20,099
2017-09-06 Mcdowell Caryn Gordon (GC & Chief Compliance Officer) Sale 10,231 14.78 148,966
2017-09-06 Mcdowell Caryn Gordon (GC & Chief Compliance Officer) Option Ex 10,231 6.57 67,217
2017-09-01 Blum Robert I (President & CEO) Sale 5,000 14.75 73,750
2017-09-01 Gage L Patrick (Director) Sale 5,000 14.73 73,655
2017-09-01 Gage L Patrick (Director) Option Ex 5,000 4.02 20,099
2017-08-31 Morgan Bradley Paul (SVP Drug Discovery & Early Dev) Sale 118,330 15.00 1,774,950
2017-08-31 Morgan Bradley Paul (SVP Drug Discovery & Early Dev) Option Ex 118,330 8.65 1,023,436
2017-08-31 Costa Santo J (Director) Sale 5,000 15.00 75,000
2017-08-31 Costa Santo J (Director) Option Ex 5,000 4.44 22,200
2017-08-29 Gage L Patrick (Director) Sale 5,000 14.00 70,000
2017-08-29 Gage L Patrick (Director) Option Ex 5,000 4.02 20,099
2017-08-29 Costa Santo J (Director) Sale 5,000 14.00 70,000
2017-08-29 Costa Santo J (Director) Option Ex 5,000 4.44 22,200
2017-08-08 Mcdowell Caryn Gordon (GC & Chief Compliance Officer) Sale 11,348 12.51 141,963
2017-08-08 Mcdowell Caryn Gordon (GC & Chief Compliance Officer) Option Ex 9,538 6.57 62,664
2017-08-01 Blum Robert I (President & CEO) Sale 5,000 13.78 68,905
2017-07-03 Blum Robert I (President & CEO) Sale 5,000 12.16 60,780
2017-06-01 Blum Robert I (President & CEO) Sale 5,000 13.62 68,125
2016-12-29 Malik Fady Ibraham (EVP Research & Development) Sale 1,326 12.52 16,600
2016-12-28 Malik Fady Ibraham (EVP Research & Development) Sale 4,307 12.31 53,032
2015-08-31 Gage L Patrick (Director) Buy 1,000 6.95 6,950
2015-08-20 Gage L Patrick (Director) Buy 10,000 6.51 65,100
2015-05-06 Gage L Patrick (Director) Buy 10,000 5.71 57,070
2015-03-11 Wolff Andrew A (SVP & CMO) Sale 21,875 7.81 170,843
2015-03-11 Wolff Andrew A (SVP & CMO) Option Ex 21,875 6.30 137,812
2014-12-30 Malik Fady Ibraham (SVP Research & Development) Sale 21,630 6.75 145,915
2014-05-09 Gage L Patrick (Director) Buy 10,850 4.09 44,430
2014-02-25 Dart Kenneth Bryan (10% Owner) Buy 500,000 8.00 4,000,000
2013-09-03 Malik Fady Ibraham (SVP Research & Early Dev) Option Ex 14,583 .00 0
2013-09-03 Cragg David (SVP Human Resources) Option Ex 10,416 .00 0
2013-09-03 Blum Robert I (President & CEO) Option Ex 29,166 .00 0
2013-09-03 Barbari Sharon Surrey (EVP, Finance & CFO) Option Ex 16,666 .00 0
2013-09-03 Wolff Andrew A (SVP Clinical R&D, CMO) Option Ex 14,583 .00 0
2012-11-14 Dow Stephen M Sale 1,742,950 .61 1,063,199
2012-09-04 Malik Fady Ibraham (SVP Research & Early Dev) Option Ex 87,500 .00 0
2012-09-04 Cragg David (SVP Human Resources) Option Ex 62,500 .00 0
2012-09-04 Blum Robert I (President & CEO) Option Ex 175,000 .00 0
2012-09-04 Barbari Sharon Surrey (EVP, Finance & CFO) Option Ex 100,000 .00 0
2012-09-04 Wolff Andrew A (SVP Clinical R&D, CMO) Option Ex 87,500 .00 0
2010-06-03 Schmertzler Michael Sale 10,764 3.00 32,292
2010-06-03 Sabry James H (Other) Sale 50,000 2.91 145,450
2010-06-03 Sabry James H (Other) Option Ex 50,000 .58 28,998
2010-05-27 Schmertzler Michael Sale 57,608 3.00 172,824
2010-05-19 Schmertzler Michael Sale 16,239 3.00 48,717
2010-05-18 Schmertzler Michael Sale 414,588 3.00 1,243,764
2010-05-18 Sabry James H (Other) Sale 25,000 3.02 75,375
2010-05-18 Sabry James H (Other) Option Ex 25,000 .58 14,499
2010-05-12 Schmertzler Michael Sale 82,738 3.00 248,214
2010-05-12 Sabry James H (Other) Sale 10,000 3.00 30,000
2010-05-12 Sabry James H (Other) Option Ex 10,000 1.20 12,000
2010-05-11 Schmertzler Michael Sale 36,500 3.00 109,500
2010-05-06 Schmertzler Michael Sale 33,446 3.03 101,341
2010-05-05 Schmertzler Michael Sale 402,100 3.04 1,222,384
2010-04-26 Sabry James H (Other) Sale 10,000 3.17 31,750
2010-04-26 Sabry James H (Other) Option Ex 10,000 1.20 12,000
2010-03-31 Sabry James H (Other) Sale 10,000 3.23 32,340
2010-03-31 Sabry James H (Other) Option Ex 10,000 1.20 12,000
2010-02-18 Blum Robert I (President & CEO) Sale 500 3.14 1,570
2010-02-18 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2010-02-11 Blum Robert I (President & CEO) Sale 500 2.96 1,480
2010-02-11 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2010-01-19 Blum Robert I (President & CEO) Sale 500 3.34 1,670
2010-01-19 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2010-01-05 Blum Robert I (President & CEO) Sale 500 3.11 1,555
2010-01-05 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-12-18 Rabson Michael (SVP Business Dev/Legal & GC) Option Ex 15,000 1.85 27,750
2009-12-16 Sabry James H (Director) Sale 20,000 3.04 59,947
2009-12-16 Sabry James H (Director) Option Ex 20,000 .58 11,600
2009-12-15 Blum Robert I (President & CEO) Sale 500 3.05 1,525
2009-12-15 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-12-15 Sabry James H (Director) Sale 34,500 3.06 105,708
2009-12-15 Sabry James H (Director) Option Ex 34,500 .89 30,705
2009-12-02 Sabry James H (Director) Sale 48,906 3.14 153,711
2009-12-02 Sabry James H (Director) Option Ex 48,906 .58 28,365
2009-12-01 Blum Robert I (President & CEO) Sale 500 3.12 1,560
2009-12-01 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-11-24 Blum Robert I (President & CEO) Sale 500 3.47 1,735
2009-11-24 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-11-17 Sabry James H (Director) Sale 48,800 3.45 168,506
2009-11-17 Sabry James H (Director) Option Ex 48,800 1.20 58,560
2009-11-16 Sabry James H (Director) Sale 66,000 3.42 225,390
2009-11-16 Sabry James H (Director) Option Ex 66,000 1.20 79,200
2009-11-16 Barbari Sharon Surrey (EVP, Finance & CFO) Option Ex 2,000 3.37 6,740
2009-11-13 Sabry James H (Director) Sale 66,200 3.35 221,968
2009-11-13 Sabry James H (Director) Option Ex 35,940 .58 20,845
2009-11-10 Blum Robert I (President & CEO) Sale 500 3.24 1,620
2009-11-10 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-10-22 Blum Robert I (President & CEO) Sale 500 4.77 2,385
2009-10-22 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-10-08 Blum Robert I (President & CEO) Sale 500 4.85 2,425
2009-10-08 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-10-01 Morgans David J Jr (EVP-Preclinical R&D) Sale 7,500 5.21 39,060
2009-09-28 Morgans David J Jr (EVP-Preclinical R&D) Sale 2,500 5.50 13,750
2009-09-24 Blum Robert I (President & CEO) Sale 500 4.62 2,310
2009-09-24 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-09-21 Morgans David J Jr (EVP-Preclinical R&D) Sale 7,500 4.77 35,797
2009-09-10 Blum Robert I (President & CEO) Sale 500 3.21 1,605
2009-09-10 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-08-20 Sabry James H (Director) Sale 20,000 2.85 57,000
2009-08-20 Sabry James H (Director) Option Ex 20,000 .58 11,600
2009-08-19 Sabry James H (Director) Sale 29,100 2.82 82,062
2009-08-19 Sabry James H (Director) Option Ex 29,100 .58 16,878
2009-08-18 Blum Robert I (President & CEO) Sale 500 2.81 1,405
2009-08-18 Blum Robert I (President & CEO) Option Ex 500 1.20 600
2009-08-17 Sabry James H (Director) Sale 13,400 2.76 36,984
2009-08-17 Sabry James H (Director) Option Ex 13,400 .58 7,771
2009-08-04 Blum Robert I (President & CEO) Sale 1,000 3.00 3,000
2009-08-04 Blum Robert I (President & CEO) Option Ex 1,000 1.20 1,200
2009-07-22 Blum Robert I (President & CEO) Sale 1,000 2.83 2,830
2009-07-22 Blum Robert I (President & CEO) Option Ex 1,000 1.20 1,200
2009-07-08 Blum Robert I (President & CEO) Sale 1,000 2.72 2,720
2009-07-08 Blum Robert I (President & CEO) Option Ex 1,000 1.20 1,200
2009-06-29 Sabry James H (Executive Chairman) Sale 20,000 2.89 57,840
2009-06-26 Sabry James H (Executive Chairman) Sale 20,000 2.84 56,780
2009-06-22 Blum Robert I (President & CEO) Sale 1,000 2.74 2,740
2009-06-22 Blum Robert I (President & CEO) Option Ex 1,000 1.20 1,200
2009-06-08 Blum Robert I (President & CEO) Sale 1,000 2.97 2,970
2009-06-08 Blum Robert I (President & CEO) Option Ex 1,000 1.20 1,200
2009-06-05 Sabry James H (Executive Chairman) Sale 29,800 2.87 85,377
2009-06-04 Sabry James H (Executive Chairman) Sale 30,200 2.86 86,462
2009-05-22 Blum Robert I (President & CEO) Sale 1,000 2.00 2,000
2009-05-22 Blum Robert I (President & CEO) Option Ex 1,000 1.20 1,200
2009-05-21 Schmertzler Michael (Director) Buy 1,522,840 1.97 2,999,994
2009-05-18 Blum Robert I (President & CEO) Sale 1,000 2.00 2,000
2009-05-18 Blum Robert I (President & CEO) Option Ex 1,000 1.20 1,200
2009-05-06 Blum Robert I (President & CEO) Sale 1,000 2.00 2,000
2009-05-06 Blum Robert I (President & CEO) Option Ex 1,000 1.20 1,200
2009-05-01 Blum Robert I (President & CEO) Sale 4,676 2.00 9,375
2009-05-01 Blum Robert I (President & CEO) Option Ex 4,676 1.20 5,611
2009-04-24 Blum Robert I (President & CEO) Sale 324 2.00 648
2009-04-24 Blum Robert I (President & CEO) Option Ex 324 1.20 388
2009-04-22 Blum Robert I (President & CEO) Sale 25,200 2.00 50,400
2009-04-22 Blum Robert I (President & CEO) Option Ex 25,200 1.20 30,240
2009-04-21 Blum Robert I (President & CEO) Sale 2,800 2.00 5,600
2009-04-21 Blum Robert I (President & CEO) Option Ex 2,800 1.20 3,360
2009-03-30 Blum Robert I (President & CEO) Sale 2,000 2.00 4,000
2009-03-30 Blum Robert I (President & CEO) Option Ex 2,000 1.20 2,400
2009-03-26 Blum Robert I (President & CEO) Sale 20,000 2.00 40,000
2009-03-26 Blum Robert I (President & CEO) Option Ex 20,000 1.20 24,000
2009-03-17 Blum Robert I (President & CEO) Sale 4,538 2.00 9,076
2009-03-17 Blum Robert I (President & CEO) Option Ex 4,538 .58 2,632
2009-03-16 Blum Robert I (President & CEO) Sale 962 2.00 1,924
2009-03-16 Blum Robert I (President & CEO) Option Ex 962 .58 557
2009-03-02 Morgans David J Jr (EVP-Preclinical R&D) Sale 5,000 1.56 7,800
2009-02-02 Morgans David J Jr (EVP-Preclinical R&D) Sale 5,000 2.14 10,700
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CYTK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cytokinetics Inc (symbol CYTK, CIK number 1061983) see the Securities and Exchange Commission (SEC) website.